Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.26 SGD | +0.44% | +4.63% | +15.90% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 69.37 | 70.27 | 122.5 | 165.8 | 153.2 | 175.7 |
Enterprise Value (EV) 1 | 38.95 | 46.03 | 61.97 | 95.91 | 86.6 | 104.8 |
P/E ratio | 12.5 x | 8.97 x | 6.89 x | 6.64 x | 7.66 x | 6.48 x |
Yield | 5.73% | 5.64% | 4.85% | 6.03% | 10.4% | 12.5% |
Capitalization / Revenue | 0.16 x | 0.15 x | 0.26 x | 0.27 x | 0.25 x | 0.27 x |
EV / Revenue | 0.09 x | 0.1 x | 0.13 x | 0.16 x | 0.14 x | 0.16 x |
EV / EBITDA | 3.05 x | 3.36 x | 3.02 x | 2.94 x | 3.58 x | 3.15 x |
EV / FCF | 9.17 x | 95.5 x | 1.66 x | 3.48 x | 34.6 x | 4.37 x |
FCF Yield | 10.9% | 1.05% | 60.1% | 28.7% | 2.89% | 22.9% |
Price to Book | 0.7 x | 0.68 x | 1.07 x | 1.27 x | 1.12 x | 1.22 x |
Nbr of stocks (in thousands) | 90,095 | 90,095 | 90,095 | 90,095 | 90,095 | 90,095 |
Reference price 2 | 0.7700 | 0.7800 | 1.360 | 1.840 | 1.700 | 1.950 |
Announcement Date | 4/5/19 | 4/13/20 | 4/6/21 | 4/4/22 | 4/5/23 | 4/14/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 431.3 | 455.8 | 479.7 | 603.6 | 617 | 658.4 |
EBITDA 1 | 12.77 | 13.68 | 20.49 | 32.6 | 24.22 | 33.3 |
EBIT 1 | 10.6 | 12.04 | 19.06 | 31.29 | 22.89 | 32.14 |
Operating Margin | 2.46% | 2.64% | 3.97% | 5.18% | 3.71% | 4.88% |
Earnings before Tax (EBT) 1 | 11.89 | 14.56 | 25.82 | 35.95 | 25.6 | 36.53 |
Net income 1 | 5.565 | 7.836 | 17.78 | 24.96 | 20 | 27.12 |
Net margin | 1.29% | 1.72% | 3.71% | 4.13% | 3.24% | 4.12% |
EPS 2 | 0.0618 | 0.0870 | 0.1973 | 0.2770 | 0.2220 | 0.3010 |
Free Cash Flow 1 | 4.249 | 0.482 | 37.25 | 27.56 | 2.506 | 24 |
FCF margin | 0.99% | 0.11% | 7.76% | 4.57% | 0.41% | 3.64% |
FCF Conversion (EBITDA) | 33.27% | 3.52% | 181.76% | 84.53% | 10.35% | 72.08% |
FCF Conversion (Net income) | 76.35% | 6.15% | 209.54% | 110.42% | 12.53% | 88.48% |
Dividend per Share 2 | 0.0441 | 0.0440 | 0.0660 | 0.1110 | 0.1770 | 0.2430 |
Announcement Date | 4/5/19 | 4/13/20 | 4/6/21 | 4/4/22 | 4/5/23 | 4/14/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 30.4 | 24.2 | 60.6 | 69.9 | 66.6 | 70.8 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 4.25 | 0.48 | 37.2 | 27.6 | 2.51 | 24 |
ROE (net income / shareholders' equity) | 6.13% | 8.73% | 16.2% | 21.3% | 15% | 19.3% |
ROA (Net income/ Total Assets) | 2.87% | 3.02% | 4.42% | 6.84% | 4.56% | 5.65% |
Assets 1 | 194.2 | 259.6 | 402.4 | 364.9 | 438.7 | 480 |
Book Value Per Share 2 | 1.110 | 1.150 | 1.270 | 1.450 | 1.520 | 1.600 |
Cash Flow per Share 2 | 0.4200 | 0.3800 | 0.3300 | 0.7800 | 0.3600 | 0.4300 |
Capex 1 | 4.75 | 1.21 | 1.1 | 0.74 | 0.86 | 0.35 |
Capex / Sales | 1.1% | 0.26% | 0.23% | 0.12% | 0.14% | 0.05% |
Announcement Date | 4/5/19 | 4/13/20 | 4/6/21 | 4/4/22 | 4/5/23 | 4/14/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+15.90% | 149M | |
+63.48% | 89.27B | |
-6.95% | 27.4B | |
+1.12% | 22.32B | |
+0.78% | 18.03B | |
-17.31% | 14.31B | |
+9.13% | 10.03B | |
+14.60% | 9.94B | |
-14.40% | 9.54B | |
+17.98% | 9.41B |
- Stock Market
- Equities
- AWZ Stock
- Financials Multi-Chem Limited